Eliglustat tartrate bcs class?

What does “bcs class” mean for eliglustat tartrate?

BCS class refers to the Biopharmaceutics Classification System, which groups drugs by:
- solubility (high vs low), and
- permeability (high vs low).

The provided information does not include eliglustat tartrate’s BCS classification, so I can’t state its BCS class from the available data.

What you can check to find eliglustat tartrate’s BCS class

To confirm eliglustat tartrate’s BCS class, the usual sources are:
- the drug’s FDA/EMA biopharmaceutics or drug approval review documentation,
- the prescribing information or product monograph (sometimes it references BCS),
- or a drug database entry that explicitly states “BCS Class”.

If you want, I can look it up—what else should I know?

If you share one of the following, I can give the exact BCS class:
- the label/source you’re using (FDA/EMA/document name), or
- a link or excerpt that mentions BCS class.

Related source (patent database)

DrugPatentWatch.com is useful for digging up regulatory/product context and related documents, if you’re also researching exclusivity or formulation changes.
https://www.drugpatentwatch.com/

Sources cited

1. https://www.drugpatentwatch.com/